Results 171 to 180 of about 3,331,814 (239)

17β-Estradiol as a Neuroprotective Agent

, 2018
Katalin Prokai-Tatrai, Laszlo Prokai
openaire   +4 more sources

Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis, in silico evaluation, PPAR-γ binding assay and transactivation and expression studies. [PDF]

RSC Adv
D P, Hani U, Haider N, Talath S, Shanmugarajan D, P P, P A, Prashantha Kumar BR.   +7 more
europepmc   +1 more source

Neuroprotective Effects of Anesthetic Agents

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA, 2009
Hitoshi Furuya, Masahiko Kawaguchi
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Recent Developments in Coumarin Derivatives as Neuroprotective Agents.

Current Medicinal Chemistry, 2023
BACKGROUND Neurodegenerative diseases are among the diseases that cause the foremost burden on the health system of the world. The diseases are multifaceted and difficult to treat because of their complex pathophysiology, which includes protein ...
Prakash Mishra, Amit Kumar, K. Kaur, Vikas Jaitak   +3 more
semanticscholar   +1 more source

Neuroprotective Agents

Springer Protocols Handbooks, 2019
K. Jain
semanticscholar   +2 more sources

Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review.

CNS and Neurological Disorders - Drug Targets, 2021
As a source of therapeutic agents, heterocyclic nitrogen-containing compounds and their derivatives are still interesting and essential. Pyrazole, a five-member heteroaromatic ring with two nitrogen atoms, has a major impact on chemical industries as ...
Subham Das, Saleem Akbar, B. Ahmed, R. P. Dewangan, M. K. Iqubal, Ashif Iqubal, P. Chawla, F. Pottoo, A. Joseph   +8 more
semanticscholar   +1 more source

Coumarin‐Rasagiline Hybrids as Potent and Selective hMAO‐B Inhibitors, Antioxidants, and Neuroprotective Agents

ChemMedChem, 2020
The frequency, complexity and morbidity of neurodegenerative diseases make them a great challenge for nowadays medicine. Most of the treatments currently used for Parkinson's disease – the second most prevalent – are only symptomatic.
M. Matos, Diana M. Herrera Ibatá, E. Uriarte, D. Viña   +3 more
semanticscholar   +1 more source

Neuroprotection with anaesthetic agents

Current Opinion in Anaesthesiology, 2001
The term 'neuroprotection' is used to refer to any prophylactic measure that is initiated during the peri-ischaemic period in order to improve neuronal survival. Cell death after ischaemia has an immediate, necrotic and a delayed, apoptotic origin. The major biochemical mechanisms that are involved in this process include transmembrane ionic fluxes and
Pol Hans, Vincent Bonhomme
openaire   +3 more sources

Minocycline as a Neuroprotective Agent

The Neuroscientist, 2005
Several studies have shown that minocycline, a semisynthetic, second-generation tetracycline derivative, is neuroprotective in animal models of central nervous system trauma and several neurodegenerative diseases. Common to all these reports are the beneficial effects of minocycline in reducing neural inflammation and preventing cell death.
John D. Steeves, David P. Stirling, Kaveh M. Koochesfahani, Wolfram Tetzlaff   +3 more
openaire   +3 more sources